Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach

Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach

Background Small cell lung cancer (SCLC) is a highly malignant cancer characterized by metastasis and an extremely poor prognosis. Although combined chemoimmunotherapy improves the prognosis of extensive-stage (ES)-SCLC, the survival benefits remain limited. Furthermore, no reliable biomarker is ava...

Full description

Bibliographic Details
Main Authors: Jing Zhao, Jie Zhao, Xue Yang, Yang Xia, Wen Li, Yayi He, Kun Huang, Liang Zeng, Yongchang Zhang, Jiaqi Zhou, Yin Zhu, Yi Gao, Panwen Tian, Qiyuan Wang, Mailin Chen
Format: Article
Language:English
Published: BMJ Publishing Group 2023-09-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/11/9/e007492.full

Internet

https://jitc.bmj.com/content/11/9/e007492.full

Similar Items